ABL Diagnostics to acquire TEXCELL assets and operations for about €2.9 million

The court-approved deal adds TEXCELL’s virology and biosafety capabilities, keeps operations at Genopole in Évry-Courcouronnes, and transfers 29 employees as ABL Diagnostics expands infectious disease activities.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.